Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Deborah Kim Glencross"'
Autor:
Naseem Cassim, Lindi Marie Coetzee, Manuel Pedro da Silva, Wendy Susan Stevens, Deborah Kim Glencross
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0292062 (2023)
BackgroundCoronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, China. Due to the rapid spread globally, it was declared a pandemic in March 2020. Social distancing an
Externí odkaz:
https://doaj.org/article/3fcfa72668784a9fb8f7b818e42948c9
Autor:
Naseem Cassim, Michael Mapundu, Victor Olago, Turgay Celik, Jaya Anna George, Deborah Kim Glencross
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Prostate cancer (PCa) is the leading male neoplasm in South Africa with an age-standardised incidence rate of 68.0 per 100,000 population in 2018. The Gleason score (GS) is the strongest predictive factor for PCa treatment and is
Externí odkaz:
https://doaj.org/article/e5c0a2466a1d4101804a3a3151c4cc73
Publikováno v:
South African Medical Journal, Vol 106, Iss 6, Pp 507-513 (2017)
Background. South Africa (SA)’s Comprehensive HIV and AIDS Care, Management and Treatment (CCMT) programme has reduced new HIV infections and HIV-related deaths. In spite of progress made, 11.2% of South Africans (4.02 million) were living with HIV
Externí odkaz:
https://doaj.org/article/18ca081650704cc0992bb50e38ae24ff
Autor:
Lindi-Marie Coetzee, Naseem Cassim, Charlotte Sriruttan, Mabatho Mhlanga, Nelesh P Govender, Deborah Kim Glencross
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198993 (2018)
INTRODUCTION:Cryptococcal meningitis (CM) is an opportunistic fungal disease with a high mortality among HIV-positive patients with severe immunosuppression (CD4 count
Externí odkaz:
https://doaj.org/article/9066f79932934fe4b3d70a5ed9b3d266
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171675 (2017)
INTRODUCTION:Cryptococcal meningitis is a major cause of mortality and morbidity in countries with high HIV prevalence, primarily affecting patients whose CD4 are < = 100 cells/μl. Routine Cryptococcal Antigen (CrAg) screening is thus recommended in
Externí odkaz:
https://doaj.org/article/8481609400e8427693f466c5cd1d0512
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182154 (2017)
INTRODUCTION:During 2016, the National Health Laboratory Service (NHLS) introduced laboratory-based reflexed Cryptococcal antigen (CrAg) screening to detect early Cryptococcal disease in immunosuppressed HIV+ patients with a confirmed CD4 count of 10
Externí odkaz:
https://doaj.org/article/4660fc73224743e7a439c38786f66b91
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156266 (2016)
BACKGROUND:The BD-FACSPresto™ CD4 is a new, point-of-care (POC) instrument utilising finger-stick capillary blood sampling. This study evaluated its performance against predicate CD4 testing in South Africa. METHODS:Phase-I testing: HIV+ patient sa
Externí odkaz:
https://doaj.org/article/5dd5cd2dfc6149e3859592ced5c2c783
BackgroundReflex Cryptococcal antigen (CrAg) testing in HIV-positive patients is done routinely at 47 laboratories in South Africa on samples with a confirmed CD4 count ObjectiveThis study aimed to verify the diagnostic performance of newer CrAg LFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec6d5f5a3e734311eaa282c1c66aa51
https://doi.org/10.1101/2022.03.02.22271757
https://doi.org/10.1101/2022.03.02.22271757
Autor:
Denise, Lawrie, Lindi Marie, Coetzee, Piet, Becker, Johnny, Mahlangu, Wendy, Stevens, Deborah Kim, Glencross
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 99(4)
Recent advances in full blood count and CD4 technology, coupled with the changing population demographics of the Gauteng region, have necessitated reevaluation of the reference ranges currently in use.A cross-sectional study of 631 female and 88 male
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 98(8)